7 months ago
🌈 มุมมองของผู้เชี่ยวชาญ: ตัวเลือกการรักษาด้วย CAR-T ในผู้ป่วยไทย🌈 https://www.medtourcn.com/wp-content/uploads/2024/03/480P泰英字-上海同济泰国患者医生吹一波CAR-T优势2.mp4 🌸 ในแผนกโรคเลือดข...
7 months ago
🌈Expert Perspective: Options for CAR-T Therapy in Thai Patients🌈 https://www.medtourcn.com/wp-content/uploads/2024/03/480P-上海同济泰国患者医生吹一波CAR-T优势2.mp4 🌺In the Hematology Dep...
7 months ago
🎉 #PNAS Breaking News: Revolutionary CAR-T Cell Therapy Successfully Treats Autoimmune Disease in China! 🎉 PNAS In a groundbreaking development, Chinese medical experts have achieved a milestone in...
7 months ago
Can CAR-T MM(multiple myeloma) be cured CAR-T therapy targeting antigens related to multiple myeloma has brought new hope for curing this disease in clinical medicine. Recent research findings have...
7 months ago
What are the products of CAR-T approved for multiple myeloma William Casler, a patient from France, was diagnosed with multiple myeloma in 2009, and his journey of fighting cancer has been long and...
7 months ago
Exploring the Frontier:CAR-T Trials for Multiple Myeloma and Their Transformative Impact Multiple myeloma (MM) treatment has made remarkable progress over the past two decades, significantly improv...
7 months ago
CAR-T in Multiple Mmyeloma,What are the CAR-T therapies approved by FDA and pending approval in 2024 Currently, the FDA has approved six CAR-T cell therapies Tisagenlecleucel (Kymriah) – Ind...
7 months ago
Abecma and Carvykti BCMA CAR-T Therapies Poised for Frontline Use, Market Size Expected to Expand Six-fold March 15,2024,the FDA Oncologic Drugs Advisory Committee (ODAC) held a full-day meeting to...
7 months ago
🩸 Breakthrough in Multiple Myeloma Treatment! 🩺 LANCET 🔬Targeting GPRC5D with CAR-T Cells shows immense potential in treating relapsed or refractory multiple myeloma patients. Multiple myeloma, a ...
7 months ago
T cell myeloma,The Lancet Haematology:GPRC5D-Targeted CAR-T Cell Therapy Shows Promising Potential for Relapsed or Refractory Multiple Myeloma OriCAR-017:a first-in-human, single-centre, single-arm...
7 months ago
Latest news on Janssen CAR-T Multiple Myeloma product Ciltacabtagene Autoleucel(Carvykti,LCAR-B38M,JNJ-4528) Ciltacabtagene Autoleucel (LCAR-B38M, JNJ-4528, Cilta-cel, Carvykti) Status: Approved fo...
7 months ago
CART T Multiple Myeloma Benefits Relapsed or Refractory Adult Patients CARsgen Therapeutics recently announced that the National Medical Products Administration (NMPA) of China has officially appro...
By using our site, you agree to our Terms and Conditions and Privacy Policy.Advanced Medicine In China does not provide medical advice, diagnosis, or treatment. The information provided on this site is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her existing physician.
© Copyright 2023 Advanced Medicine In China. All rights reserved.
